<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
"http://www.w3.org/TR/html4/strict.dtd">
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

	<!-- Basic Page Needs
  ================================================== -->
    <script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/jquery-1.8.3.min.js" type="text/javascript"></script>
    <script type="text/x-mathjax-config">
	MathJax.Hub.Config({
	  "HTML-CSS": { linebreaks: { automatic: true } },
	         SVG: { linebreaks: { automatic: true } }
	});
	</script>
    <script type="text/javascript" src="https://cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
	<meta charset="utf-8">
	<title>Heart &amp; Circulation</title>
	<meta name="description" content="Course Notes for Heart &amp; Circulation">
	<meta name="author" content="Kevan Lu">
	<meta name="robots" content="noindex,nofollow"/>
	
	<!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1.0, maximum-scale=1.0, target-densityDpi=device-dpi" />
	
	<!-- CSS
  ================================================== -->
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/layout.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/content.css">
	<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/print.css">
	<link href="http://maxcdn.bootstrapcdn.com/font-awesome/4.2.0/css/font-awesome.min.css" rel="stylesheet">	
	
	<script>
	  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
	  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
	  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
	  })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

	  ga('create', 'UA-40381402-3', 'auto');
	  ga('send', 'pageview');
	</script>

	<!-- Favicons
	================================================== -->
	<link rel="shortcut icon" href="https://dl.dropboxusercontent.com/u/157117/Class%20References/favicon.png" type="image/png">
</head>
<body>
    <div id="home-overlay">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<div id="header-search-icon"><a id="header-search-button"><i class="fa fa-search"></i></a></div>
</div>
<div id="header-search-bar">
	<form class="search" action="http://www.schulichnotes.com/cardiology/search.html">
	<div><input type="text" value="Search Heart &amp; Circulation" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	</form>
</div>
<div id="overlay"><h1><a style="border:none;" href="http://www.schulichnotes.com/cardiology">Heart &amp; Circulation</a></h1></div>
    <div class="sidebar-background"></div>
    <div class="sidebar">
        <!-- Displays a Search Bar-->
<div class="search-wrapper">
	<div class="index"><a href="http://www.schulichnotes.com"><i class="fa fa-stethoscope"></i> Schulich Notes</a></div>
	<form class="search" action="http://www.schulichnotes.com/cardiology/search.html">
	<div style="float: left;"><input type="text" value="Search Heart &amp; Circulation" onfocus="if(this.value==this.defaultValue)this.value='';" onblur="if(this.value=='')this.value=this.defaultValue;" name="q" id="tipue_search_input"></div>
	<div style="float: left;"><input type="button" id="tipue_search_button" onclick="this.form.submit();"></div>
	<div style="clear: left;"></div>
	</form>
</div>

<div class="course-index">
	<a href="http://www.schulichnotes.com/cardiology">Heart &amp; Circulation</a>
</div>

        <nav>	
	<li class="week">Week 1</li>
	<ul>
		<li class="day">January 13</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/13/intro-cardiac-physiology.html">Introduction to Cardiac Physiology</a></li></ul>
		<li class="day">January 14</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/14/intro-cardiac-physiology-2.html">Introduction to Cardiac Physiology II</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/14/heart-pump.html">The Heart as a Pump I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/14/bp-reg-vascular-flow.html">BP Regulation &amp Vascular Flow</a></li></ul>
		<li class="day">January 15</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/15/cardiac-electrical-physiology.html">Cardiac Electrical Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/15/interpreting-ecgs-1a.html">Interpreting ECGs Ia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/15/interpreting-ecgs-1b.html">Interpreting ECGs Ib</a></li></ul>
		<li class="day">January 16</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/16/heart-pump-2.html">The Heart as a Pump II</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/16/heart-pump-3.html">The Heart as a Pump III</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/16/anatomy-lab-heart.html">Heart Anatomy Lab</a></li></ul>
		<li class="day">January 17</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/17/intro-cardiovascular-pharmacology.html">Cardiovascular Pharmacology I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/17/intro-cardiovascular-pharmacology-2.html">Cardiovascular Pharmacology II</a></li></ul>
	</ul>
	<li class="week">Week 2</li>
	<ul>
		<li class="day">January 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/20/valvular-heart-disease-cases.html">Valvular Heart Disease Cases</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/20/imaging-cardiovascular-disease.html">Imaging in Cardiovascular Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/20/into-heart-sounds.html">Introduction to Heart Sounds</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/20/clinical-assessment-heart-sounds.html">Clinical Assessment of Heart Sounds</a></li></ul>
		<li class="day">January 21</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/21/aortic-stenosis.html">Aortic Stenosis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/21/mitral-regurgitation.html">Mitral Regurgitation</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/21/mitral-stenosis.html">Mitral Stenosis</a></li></ul>
		<li class="day">January 22</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/22/aortic-regurgitation.html">Aortic Regurgitation</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/22/endocarditis.html">Endocarditis</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/22/interpreting-ecgs-2.html">Interpreting ECGs II</a></li></ul>
		<li class="day">January 23</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/23/outline-congenital-heart-disease.html">An Outline of Congenital Heart Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/23/exercise-physiology.html">Exercise Physiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/23/valvular-pericardial-cases.html">Valvular Pericardial Cases</a></li></ul>
		<li class="day">January 24</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/24/surgical-management-valvular-disease.html">Surgical Management in Valvular Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/24/case-based-learning.html">Case Based Learning</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/24/clinical-problems-pediatric-cardiology.html">Clinical Problems in Pediatric Cardiology</a></li></ul>
	</ul>
	<li class="week">Week 3</li>
	<ul>
		<li class="day">January 27</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/27/case-based-learning-atherosclerosis.html">Atherosclerosis Case Based Learning</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/27/investigations-ischemic-heart-disease.html">Investigations in Ischemic Heart Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/27/vascular-pathology.html">Vascular Pathology</a></li></ul>
		<li class="day">January 28</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/28/cholinergic-pharmacology-1.html">Cholinergic Pharmacology I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/28/physiology-hypertension.html">Physiology of Hypertension</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/28/microcirculation-physiology.html">Microcirculation Physiology</a></li></ul>
		<li class="day">January 29</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/29/pharmacology-dyslipidemia.html">Pharmacology for Dyslipidemia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/29/lipids-genes-CAD.html">Lipids, Genes, and CAD</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/29/anatomy-lab-mediastinum.html">Mediastinum Anatomy Lab</a></li></ul>
		<li class="day">January 30</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/30/aneurysms.html">Aneurysms</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/30/case-based-learning-peripheral-vascular-disease.html">Peripheral Vascular Disease Cases</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/30/management-hypertension.html">Management of Hypertension</a></li></ul>
		<li class="day">January 31</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/31/vascular-small-group.html">Vascular Small Group Session</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/31/hypertension-small-group.html">Hypertension Small Group Session</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/01/31/cholinergic-pharmacology-2.html">Cholinergic Pharmacology II</a></li></ul>
	</ul>
	<li class="week">Week 4</li>
	<ul>
		<li class="day">Monday, February 3</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/03/primary-prevention-cardiovascular-disease.html">Primary Prevention of Cardiovascular Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/03/secondary-prevention-cardiovascular-disease.html">Secondary Prevention of Cardiovascular Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/03/management-chronic-coronary-disease.html">Management of Chronic Coronary Disease</a></li></ul>
		<li class="day">Tuesday, February 4</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/04/coronary-circulation.html">Coronary Circulation</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/04/coronary-artery-disease-mi-pci-1.html">Coronary Artery Disease &mdash; MI &amp; PCI I</a></li></ul>
		<li class="day">Wednesday, February 5</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/05/nutrition-cardiovascular-disease.html">Nutrition and Cardiovascular Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/05/ischemic-heart-disease-pathology.html">Ischemic Heart Disease Pathology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/05/coronary-artery-disease-mi-pci-2.html">Coronary Artery Disease &mdash; MI &amp; PCI II</a></li></ul>
		<li class="day">Thursday, February 6</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/06/pediatric-cardiology.html">Child Health &mdash; Pediatric Cardiology</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/06/chest-pain-small-group.html">Chest Pain Small Group</a></li></ul>
		<li class="day">Friday, February 7</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/07/surgical-management-cardiovascular-disease.html">Surgical Management of Cardiovascular Disease</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/07/intervention-cardiac-patient-cases.html">Intervention in Cardiac Patient Cases</a></li></ul>
	</ul>
	<li class="week">Week 5</li>
	<ul>
		<li class="day">Monday, February 10</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/10/heart-failure-cases.html">Heart Failure Cases</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/10/heart-failure-1.html">Heart Failure I</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/10/physiology-heart-failure.html">Physiology of Heart Failure</a></li></ul>
		<li class="day">Tuesday, February 11</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/11/heart-failure-2.html">Heart Failure II</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/11/heart-failure-3.html">Heart Failure III</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/11/heart-failure-small-groups.html">Heart Failure Small Groups</a></li></ul>
		<li class="day">Wednesday, February 12</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/12/mechanism-arrythmia.html">Mechanism of Arrythmia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/12/antiarrythmics.html">Antiarrythmics</a></li></ul>
		<li class="day">Thursday, February 13</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/13/atrial-fibrillation.html">Atrial Fibrillation</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/13/supraventricular-tachycardia.html">Supraventricular Tachycardia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/13/ventricular-tachycardia.html">Ventricular Tachycardia</a></li></ul>
		<li class="day">Friday, February 14</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/14/interpreting-ecgs-3.html">Interpreting ECGs III &mdash; Cases</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/14/bradycardia.html">Bradycardia</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/14/syncope.html">Syncope</a></li></ul>
	</ul>
	<li class="week">Week 6</li>
	<ul>
		<li class="day">Tuesday, February 18</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/18/end-of-life-care.html">End of Life Care</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/18/arrythmia-small-groups.html">Arrythmia Small Groups</a></li></ul>
		<li class="day">Wednesday, February 19</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/19/ecg-exercises.html">ECG Exercises</a></li><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/19/integrated-wrap-up-cases.html">Integrated Wrap-up Cases</a></li></ul>
		<li class="day">Thursday, February 20</li>
		<ul><li class="lecture"><a href="http://www.schulichnotes.com/cardiology/2014/02/20/exam-review-cardiovascular-jeopardy.html">Final Exam Review</a></li></ul>
	</ul>
</nav>
    </div>
    <div class="content-offset">
        <div class="content-background"></div>
        <div class="content">
            <div class="single post">
                <!-- Post Layout -->
                <div class="title"><h1>Cardiovascular Pharmacology II</h1></div>
                <info datetime="2014-01-17">
                    <span class="author"><a href="https://dl.dropboxusercontent.com/u/157117/notes-reference/jekyll/_site/contributors.html#kevanlu">Kevan Lu</a></span>
                    <span class="date">Friday, January 17, 2014</span>
                </info>
                <div class="body"><h1 id='nitrodilators'>Nitrodilators</h1>
<hr />
<ol>
<li>
<p><strong>Organic nitrates</strong> &#8594; <strong>Nitroglycerin</strong></p>
</li>

<li>
<p><strong>Nitroprusside</strong> (eg. <em>Sodium Nitroprussed</em>)</p>

<ul>
<li>Intravenous drug that causes the release of <em>nitric oxide</em></li>

<li>Arterial vasodilator.</li>
</ul>
</li>

<li>
<p><strong>Nitric Oxide</strong></p>

<ul>
<li>Recall, that this was the <em>Endiothelium Derived Relaxing Factor</em></li>

<li>It&#8217;s a potent vasodilator.</li>
</ul>
</li>
</ol>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/exhh453a.png' />
<ul>
<li>All the nitrodilators work by producing <em>nitric oxide</em>, which is a vasodilator.</li>

<li>They cause <em>vascular smooth muscle relaxation</em></li>

<li>Nitroglycerin was originally used to make dynamite! Made Alfred Nobel rich &#8594; founded the Nobel Prizes.</li>

<li>Nitric oxide functions by <strong>activating guanylate cyclase &#8594; cGMP</strong>.</li>

<li>The <em>cGMP</em> then directly causes the vascular relaxation.</li>
</ul>

<h4 id='effects_of_nitrates'><strong>Effects of Nitrates</strong></h4>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/jjgxafz-.png' />
<ol>
<li>
<p><strong>Vasodilation</strong></p>

<ul>
<li>
<p><em>Nitrates cause arterial and venous dilation.</em> This decreases preload &#8594; reduces ventricular stretch!</p>
</li>

<li>
<p><em>Coronary artery dilation</em></p>

<ul>
<li>Can be useful in patients with <em>coronary artery disease</em>, and the patients are ischemic.</li>

<li>Will improve <em>perfusion to the endocardium</em></li>
</ul>
</li>
</ul>
</li>

<li>
<p><strong>Reduces Myocardial Oxygen Demand</strong></p>

<ul>
<li>Decreases <em>preload</em> because of vasodilation &#8594; decreases wall stress.</li>

<li>Decreased BP also <em>decreases afterload</em>.</li>

<li>Reduced wall stress may also improve ventricular perfusion, because high ventricular pressures reduce coronary circulation!</li>
</ul>
</li>
</ol>

<ul>
<li>Hence nitrates effectively <strong>reduce oxygen demand</strong> and <strong>improve oxygen supply</strong>.</li>
</ul>

<h4 id='caveat'><strong>Caveat</strong></h4>

<ul>
<li>
<p>Nitrates could potentially make myocardial <strong>oxygen supply worse</strong>, or make <strong>oxygen demand higher</strong></p>
</li>

<li>
<p><em>How could this happen?</em></p>

<ul>
<li>If patients are hypotensive because of the vasodilation, you went to far, and coronary perfusion would actually drop!</li>

<li>Could trigger the <em>baroreflex</em> because of a drop in blood pressure, causing an increase in heart rate. This can cause a <strong>reflex tachycardia</strong> which increases oxygen consumption!</li>
</ul>
</li>
</ul>

<h4 id='nitrate_tolerance'><strong>Nitrate Tolerance</strong></h4>

<ul>
<li>Over time, there is a loss of the hemodynamic and anti-anginal effects of nitrates.</li>

<li>People develop a <em>resistance to nitrates</em> during long-term use or from frequent dosing.</li>

<li>There are multiple hypotheses as to why this happens, but no definitive mechanism.</li>

<li>The tolerance develops pretty quickly (<strong>over 24-48 hours</strong>)</li>

<li>Hence, you have to be careful with IV nitroglycerin, or around-the-clock dosing.</li>

<li>We require a <strong>nitro free interval</strong> (<strong>around 8-10 hours</strong>) during dosing to avoid tolerance!!</li>
</ul>

<h4 id='adverse_effects'><strong>Adverse Effects</strong></h4>

<ul>
<li><em>Headache</em> (due to vasodilation in the head)</li>

<li><em>Decreased blood pressure</em> (obviously)</li>

<li><em>Withdrawal Symptoms</em> &#8594; rebound vasoconstriction could cause weekend angina/ weekend coronary events. But you shouldn&#8217;t see this if you dose properly.</li>
</ul>

<h4 id='contraindications'><strong>Contraindications</strong></h4>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/aiii7k3r.png' /><span class='sidenote'>An example of a Phosphodiesterase-5 Inhibitor would be <b>Viagra</b> (Sildenafil), which inhibits cGMP breakdown to increase vasodilation in the penis.</span>
<ul>
<li>
<p><strong>Hypotension</strong> &#8594; obviously, since nitrates reduce BP!</p>
</li>

<li>
<p><strong>Ingestion of PDE-5 inhibitor</strong>:</p>

<ul>
<li><strong>PDE5I = Phosphodiesterase-5-Inhibitor</strong></li>

<li><em>PDE-5 inhibitor &#8594; inhibits the breakdown of cGMP</em>.</li>

<li>Since nitrates <em>stimulate cGMP production</em>, using these in conjunction can cause an <em>accumulation of cGMP</em>.</li>

<li>This can cause <em>hypotension</em>.</li>

<li>Hence, we need a <strong>24-48 hour gap</strong> between dosing the two, depending on the half-life of the PDE5I.</li>
</ul>
</li>
</ul>

<blockquote>
<h4 id='summary'><strong>Summary</strong></h4>

<ul>
<li>
<p>Nitrates are used in patients with <strong>Myocardial ischemia</strong></p>
</li>

<li>
<p>The rationale for their role in treating angina is:</p>

<ul>
<li><strong>Increasing oxygen delivery</strong> &#8594; <em>vasodilating coronary arteries</em></li>

<li><strong>Decreasing oxygen demand</strong> &#8594; <em>vasodilation to reduce preload and afterload</em></li>
</ul>
</li>
</ul>
</blockquote>

<h1 id='calcium_channel_blockers_ccbs'>Calcium Channel Blockers (CCBs)</h1>
<hr />
<ul>
<li>
<p>Effectively, there are <em>two major classes of calcium channel blockers</em>.</p>
</li>

<li>
<p>Mechanistically, they function very differently. You sort of have to think of them like two different groups of drugs.</p>
</li>

<li>
<p>The two classes have different <em>indications</em>, <em>contraindications</em>, and <em>effects</em>!</p>
</li>

<li>
<p>They are as follows:</p>

<ol>
<li>
<p><strong>Dihydropyridines (DHPs)</strong> (The &#8217;<strong>___ pine</strong>&#8217; drugs)</p>

<ul>
<li>eg. <em>nifedipine</em>, <em>amlodipine</em>.</li>

<li>Primarily have a <em>vasodilation</em> effect &#8594; hence typically used with hypertension.</li>
</ul>
</li>

<li>
<p><strong>Nondihydropyridines (Non-DHPs)</strong></p>

<ul>
<li><em>Verapamil</em></li>

<li><em>Diltiazem</em></li>

<li>Have a <em>vasodilator effect</em> as well, but also act on the <em>Sinus and AV node</em></li>

<li>Hence they <em>reduce HR and contractility</em> as well!</li>

<li>Hence nondihyropyridines are similar to dihydropyridines, but do more stuff!</li>
</ul>
</li>
</ol>
</li>
</ul>

<h4 id='mechanism_of_action'><strong>Mechanism of Action</strong></h4>

<ul>
<li>
<p><strong>Calcium Channel Blockers</strong> function by <em>binding to calcium channels.</em></p>

<ul>
<li>Will <em>vasodilate smooth muscle</em></li>

<li><em>Decrease myocyte contractility</em></li>

<li>Decreases conduction through the AV node to slow heart rate, similarly to <em>Digoxin</em>.</li>
</ul>
</li>
</ul>

<h4 id='cardiac_vs_vascular_selectivity'><strong>Cardiac vs. Vascular Selectivity</strong></h4>

<ul>
<li><strong>Dihydropyridines</strong> like Amlodipine and Nifedipine are more <em>vascularly selective</em>, so they are primarily used to treat hypertension.</li>

<li><strong>Nondihydropyridines</strong> like Verapamil and Diltiazem have a much larger role in affecting the SA and AV notes, so they&#8217;re more <strong>cardiac selective</strong>, and will be used with atrial fibrillation, for instance.</li>

<li>Because of these ancillary effects, nondihydropyridines are rarely used for hypertension. Also, because they <em>reduce contractility</em>, they&#8217;re also probably not a good idea in patients with CHF.</li>
</ul>
<img src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/4r4qofex.png' />
<h4 id='indications'><strong>Indications</strong></h4>

<ul>
<li><strong>DHPs</strong> can be used for <strong>hypertension</strong>.</li>

<li><strong>Angina</strong></li>

<li><em>Atrial Fibrillation</em> rate control (Non-DHPs like Verapamil and Diltiazem). Dihydropyridines can&#8217;t be used here!</li>
</ul>

<h4 id='adverse_effects'><strong>Adverse Effects</strong></h4>

<ul>
<li>
<p><em>Hypotension</em> &#8594; vasodilation</p>
</li>

<li>
<p><em>Flushing and Headache</em> &#8594; vasodilation</p>
</li>

<li>
<p>Since Verapamil and Diltiazem affect AV condution like Digoxin, they can cause:</p>

<ul>
<li><em>Heart block</em></li>

<li><em>Bradycardia</em></li>

<li><em>Decreased cardiac output</em></li>
</ul>
</li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/fg-jf_bj.png' />
<h3 id='contraindications_for_dhps'><strong>Contraindications for DHPs</strong></h3>

<ul>
<li>Because they&#8217;re basically vasodilators, they&#8217;re contraindicated in patients with <strong>low blood pressure.</strong></li>

<li><em>Aortic Stenosis</em> is a <em>relative contraindication</em> &#8594; you don&#8217;t want to drop BP too much with a sticky aortic valve, because it increases afterload, so you need some more outward pressure.</li>

<li>CCBs have also been shown to <em>not improve outcomes</em> in patients with CHF!</li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/hsc9l8jg.png' />
<h3 id='contraindications_for_nondhps'><strong>Contraindications for Non-DHPs</strong></h3>

<ul>
<li>Patients with a <em>slow heart rate</em>.</li>

<li>Patients with a <em>low blood pressure</em>.</li>

<li>Patients with systolic failure.</li>

<li>Basically, whenever the patient already has the effects of the CCB, such as a slowed HR, a low BP, or weakened contractility, worsening the effect is obviously a bad idea!</li>
</ul>

<blockquote>
<h4 id='summary'><strong>Summary</strong></h4>

<ul>
<li><strong>Calcium Channel Blockers (CCBs)</strong> are split into <em>two classes</em>:</li>
</ul>

<ol>
<li><strong>Dihydropyridines (DHPs)</strong> &#8594; &#8217;<em>___ pine</em>&#8217; drugs like Nifedipine and Amlodipine. Mainly have a <em>vasodilatory</em> effect.</li>

<li><strong>Nondihydropyridines (Non-DHPs)</strong> &#8594; Verapamil and Diltiazem, mainly used because of their effect on AV conduction. Lowers heart rate and reduces contractility. Typically used in patients with <em>atrial fibrillation</em>. <strong>Not</strong> used with CHF!</li>
</ol>
</blockquote>

<h1 id='beta_blockers'>Beta Blockers</h1>
<hr />
<h4 id='organization_of_the_central_nervous_system'><strong>Organization of the Central Nervous System</strong></h4>

<p>Recall that the Central Nervous System was organized as follows:</p>

<ul>
<li>
<p>Afferent signals go in, and efferent signals can be either <em>autonomic</em> or <em>somatic</em>.</p>
</li>

<li>
<p>The <strong>autonomic nervous system</strong> is split into:</p>

<ol>
<li>
<p>The <strong>Sympathetic Nervous System</strong> &#8594; Rapid, fight or flight response.</p>

<ul>
<li>Dilation of the pupils &#8594; far vision.</li>

<li>Decrease of secretions and peristalsis.</li>

<li>Increased sweating.</li>

<li>Dilation of the bronchi.</li>

<li><em>Increase of the Heart Rate</em> &#8594; due to increased conduction through the AV node</li>

<li>Increased heart contractility.</li>

<li>Vasoconstriction while increasing flow to the muscles.</li>

<li><em>Glycogenolysis</em> &#8594; increased breakdown of glycogen to glucose which can be quickly consumed for energy.</li>

<li><strong>Piloerection</strong> &#8594; Hair standing on end!</li>
</ul>
</li>

<li>
<p>The <strong>Parasympathetic Nervous System</strong></p>
</li>

<li>
<p>The <strong>Enteric Nervous System</strong></p>
</li>
</ol>
</li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/331tw-pz.png' />
<h4 id='the_sympathetic_nervous_system'><strong>The Sympathetic Nervous System</strong></h4>

<ul>
<li>
<p>The SNS is <strong>thoracolumbar</strong>: Enervation moves from brain &#8594; spinal cord &#8594; thoracolumbar area &#8594; end organs.</p>
</li>

<li>
<p>The <em>neurotransmitters</em> involved are <em>catecholamines</em> &#8594; Catecholamines have a catechol ring plus an amine group &#8594; <em>Catechol + amine</em>!</p>
</li>

<li>
<p>The catecholamines that are involved are:</p>

<ul>
<li><strong>Norepinephrine/noradrenaline</strong> at <strong>adrenergic nerve terminals</strong></li>

<li><strong>Epinephrine</strong> from the <strong>adrenal medulla</strong></li>
</ul>
</li>

<li>
<p>Hence, we have <em>hormonal stimulation via epinephrine</em>, as well as <em>stimulation at the nerve terminals via norepinephrine.</em></p>
</li>
</ul>

<h4 id='adrenergic_receptor_subtypes'><strong>Adrenergic Receptor Subtypes</strong></h4>

<ul>
<li>
<p><strong>G-Protein Coupled Receptors</strong> are involved in receiving Adrenergic signals. (ha, you thought you wouldn&#8217;t ever see them again huh.)</p>
</li>

<li>
<p>There are 3 types of receptors involved:</p>

<ul>
<li>
<p><strong>Alpha Receptors</strong></p>
</li>

<li>
<p><strong>Beta Receptors</strong></p>

<ol>
<li>
<p><strong>Beta 1 Receptors</strong></p>

<ul>
<li>Increase cardiac contractility.</li>

<li>Increase heart rate.</li>

<li>Increase electrical conduction.</li>
</ul>
</li>

<li>
<p><strong>Beta 2 Receptors</strong> <span class='sidenote'>It was previously mentioned that the SNS response causes vasoconstriction, except for the muscles, where vasodilation occurs to increase flow. This vasodilation of the skeletal muscle is mediated by the <b>Beta 2 Receptors</b></span></p>

<ul>
<li>Vasodilation &#8594; particularly of the skeletal muscle.</li>

<li>Bronchodilation</li>

<li>Glycogenolysis &#8594; Production of glucose by breaking down glycogen.</li>
</ul>
</li>

<li>
<p><strong>Beta 3 Receptors</strong> &#8594; we don&#8217;t know much about these, and we have no drugs that affect them, so we ignore them!</p>
</li>
</ol>
</li>

<li>
<p><strong>Dopamine Receptors</strong></p>
</li>
</ul>
</li>

<li>
<p>Dopamine receptors will not be talked about much &#8594; they&#8217;re mostly in the <em>brain</em> and <em>kidney</em>.</p>
</li>

<li>
<p><em>Problems with dopamine in the brain</em> &#8594; <strong>Parkinson&#8217;s Disease</strong>.</p>
</li>
</ul>

<blockquote>
<h3 id='summary'><strong>Summary</strong></h3>

<ul>
<li><em>GPCRs</em> involved in adrenergic systems include <em>alpha</em>, <em>beta</em>, and <em>dopamine</em> receptors.</li>

<li>Of the <em>beta receptors</em>, the main classes we focus on are <em>beta 1 receptors</em> and <em>beta 2 receptors</em></li>

<li><strong>Beta 1 Receptors</strong> generally affect <em>heart rate</em>, <em>contractility</em>, and <em>electrical conduction</em> &#8594; affects the <strong>heart</strong>!</li>

<li><strong>Beta 2 Receptors</strong> cause <em>skeletal muscle vasodilation</em>, <em>bronchodilation</em>, and <em>glycogenolysis</em> &#8594; have a <strong>systemic effect</strong>.</li>
</ul>
</blockquote>

<h3 id='beta_blocker_therapy'><strong>Beta Blocker Therapy</strong></h3>

<ul>
<li>
<p><strong>If we block the beta-1 receptors:</strong></p>

<ul>
<li>Decrease in cardiac contractility</li>

<li>Decrease in heart rate</li>

<li>Decrease in conduction through the SA and AV nodes</li>
</ul>
</li>

<li>
<p><strong>If we block the beta-2 receptors:</strong></p>

<ul>
<li>Vasodilation</li>

<li>May have some bronchoconstriction</li>

<li>No glycogenolysis</li>
</ul>
</li>

<li>
<p>This is pretty obvious.</p>
</li>

<li>
<p><strong>Hence, beta-blockers can be used for:</strong></p>

<ul>
<li><em>Antihypertensives</em> &#8594; drop cardiac output by decreasing flow.</li>

<li><em>Post MI</em> &#8594; by decreasing HR and decreasing contractility, we decrease oxygen demand and stress on the heart. But on the other hand, we don&#8217;t want to go too far and lower the CO too much in an acute situation.</li>

<li><em>Congestive Heart Failure</em> &#8594; this is actually a surprise &#8594; wouldn&#8217;t it be a bad idea to reduce cardiac output?! The reason why it&#8217;s used is because it seems as if prolonged activation of the SNS over time seems to worsen the condition of the heart!</li>

<li><em>Migraine</em></li>

<li><em>Tremors</em></li>

<li><em>Thyrotoxicosis</em> &#8594; also known as a <em>thyroid storm</em>, associated with a <em>high sympathetic tone.</em></li>
</ul>
</li>
</ul>

<h3 id='adverse_effects'><strong>Adverse Effects</strong></h3>

<ul>
<li>
<p>The adverse effects of beta-blockers are immediately intuitive from their physiological mechanism:</p>

<ul>
<li><em>Bradycardia</em></li>

<li><em>Worsening of heart failure</em> if we drop the patient&#8217;s cardiac output too much.</li>

<li>Can cause <em>bronchoconstriction</em> &#8594; <em>bad in asthmatics</em>.</li>

<li><em>Fatigue</em></li>

<li><em>Nightmares</em></li>

<li><em>May mask the symptoms of hypoglycemia</em> &#8594; risky in <em>diabetics</em>! When patients have hypoglycemia, the body responds by sweating, elevation in the HR, tremors, etc. But with beta-blockers, this response may be masked!</li>
</ul>
</li>

<li>
<p>Interestingly, beta-blockers with <em>beta-2 activity</em> can actually worsen symptoms in patients with <em>peripheral vascular disease</em>.</p>
</li>

<li>
<p>This is because they would cause <em>skeletal muscle vasoconstriction</em>, exacerbating ischemia to the limbs. This could result in more severe claudications when walking.</p>
</li>
</ul>

<h2 id='classes_of_beta_blockers'><strong>Classes of Beta Blockers</strong></h2>

<ul>
<li><em>&#946;-blockers</em> are &#8217;<em>___ lol</em>&#8217; drugs. (Propanolol, metoprolol, etc.)</li>
</ul>

<ol>
<li>
<p><strong>Non-selective Beta Blockers</strong></p>

<ul>
<li>eg. <strong>propranolol</strong> (Inderal&#169;)</li>

<li>Propranolol blocks <em>both beta 1 and beta 2 receptors</em> &#8594; non-selective!</li>

<li>Propranolol requires a <em>large PO dose</em> because it&#8217;s metabolized in the liver with a first-pass effect when given orally. Requires a much larger PO dose than an IV one.</li>

<li>Used in patients with <em>portal hypertension &amp; GI bleeding.</em> (will see this next year)</li>

<li>Also has lots of side-effects.</li>
</ul>
</li>

<li>
<p><strong>Cardioselective Beta Blockers</strong></p>

<ul>
<li>eg. <strong>Metoprolol</strong></li>

<li>Much larger effect on the <em>heart-related Beta 1 function</em> versus the Beta 2 function!</li>

<li><strong>beta 1 block &gt; beta 2</strong></li>

<li>Also has a first-pass hepatic metabolism.</li>

<li>Indicated in all patients <em>post MI</em>, and with <em>systolic heart failure</em>.</li>
</ul>
</li>

<li>
<p><strong>Third Generation Beta Blockers</strong></p>

<ul>
<li>eg. <strong>Carvedilol</strong> (Coreg&#169;), <strong>labetalol</strong></li>

<li>Non-selective beta blocker (blocks beta 1 &amp; beta 2)</li>

<li><strong>Also has an alpha 1 blocking effect</strong></li>

<li>&#945;-receptors cause <em>vasoconstriction</em></li>

<li>Shown to increase survival in heart failure (COMET trial comparing metoprolol &amp; carvedilol &#8594; cardioselective &#946;-blocker vs. third-gen &#946;-blocker)</li>
</ul>
</li>
</ol>

<h3 id='why_do_beta_adrenergic_blockers_have_beneficial_effects'><strong>Why do Beta Adrenergic Blockers have Beneficial Effects?</strong></h3>

<p>There are lots of potential reasons as to why &#946;-blockers can be beneficial:</p>

<ul>
<li>Inhibition of the <em>cardiotoxicity of catecholamines</em> &#8594; if catecholamines constantly bombard the heart, it can be toxic over time!</li>

<li>For instance, in patients with a bleed in the head (a <em>subarachnoid hemorrhage</em>), there is a <em>massive acute catecholamine release</em>, which can cause <em>acute myocardial dysfunction</em>, and a marked low ejection fraction, which is thought to be due to acute catecholamine toxicity.</li>

<li>Decrease in HR may reduce strain on the heart.</li>

<li>Antihypertensive, antianginal, antiarrhytmic.</li>
</ul>

<h4 id='relative_contraindications'><strong>Relative Contraindications</strong></h4>

<ul>
<li>Follow from the physiology: <em>low BP</em>, <em>low HR</em>, <em>clinically unstable</em>, <em>reactive airway disease like asthma</em></li>
</ul>
<img class='right' src='https://dl.dropboxusercontent.com/spa/4sm4d57annqq50o/7oaljmx0.png' />
<h4 id='catecholamines_and_survival_with_heart_failure'><strong>Catecholamines and Survival with Heart Failure</strong></h4>

<ul>
<li>
<p>In <em>heart failure</em>, a number of compensatory responses are turned on &#8594; activation of the RAAS system, increased sympathetic tone.</p>
</li>

<li>
<p>Increased circulating catecholamines have been seen to decrease long-term survival!</p>
</li>

<li>
<p>In the figure on the right <em>PNE = Plasma Norepinephrine Levels</em></p>
</li>

<li>
<p>Hence, we have improved mortality in systolic heart failure if we start blocking these compensatory responses!</p>

<ul>
<li>Blocking the RAAS with an <em>ACEI/ARB, and an Aldosterone antagonist.</em></li>

<li>Blocking the sympathetic response with <em>&#946;-blockers</em></li>
</ul>
</li>
</ul>

<blockquote>
<h4 id='summary'><strong>Summary</strong></h4>

<p>&#946;-blocker medications can be split into <em>3 groups</em>:</p>

<ol>
<li><strong>Non-selective &#946;-blockers</strong> &#8594; <em>&#946;-1 &amp; &#946;-2;</em>. eg. <em>propanolol</em></li>

<li><strong>Cardioselective &#946;-blockers</strong> &#8594; <em>&#946;-1 &gt; &#946;-2</em>. eg. <em>metoprolol</em></li>

<li><strong>Third-generation &#946;-blockers</strong> &#8594; <em>&#946;-1, &#946;-2, &amp; &#945;-1</em>. eg. <em>carvedilol</em>, <em>labetalol</em></li>
</ol>

<ul>
<li>&#945;-1 receptors are involved in <em>vasoconstriction</em> (aside from the skeletal muscles, which are <em>vasodilated by &#946;-2 receptors</em>).</li>
</ul>
</blockquote>

<h2 id='conclusions'><strong>Conclusions</strong></h2>

<ul>
<li>Note that there is a lot of overlap between medications!</li>

<li>For instance, <em>digoxin</em>, <em>Non-DHP CCBs</em> like Verapamil and Diltiazem, and <em>&#946;-blockers</em> could all be used to treat atrial fibrillation!</li>

<li>The one you would use would depend on the patient and their contraindications!</li>

<li>eg. You would use <em>digoxin</em> if it was an old, sedentary patient, because the effect on the PSNS is mild and the fact that it&#8217;s easily overcome by exercise isn&#8217;t such a big deal if the patient isn&#8217;t very active.</li>

<li>If the patient was younger, Verapamil might be better (except if they have CHF, because the <em>vasodilatory</em> effect may worsen morbidity and mortality)</li>

<li>Notes for the lecture can be found in these <a href='https://dl.dropboxusercontent.com/u/157117/Class%20References/hc_13_14_Champion_Introduction_Cardiac_Pharmacology_Notes.pdf'>summary notes</a>.</li>

<li>There is also a <a href='https://dl.dropboxusercontent.com/u/157117/Class%20References/hc_13_14_Champion_Pharmacology_Summary.pdf'>spreadsheet</a> summarizing the context in which you&#8217;d use each drug!</li>
</ul>                
                </div>
            </div>
            <div class="pagination">
                <div style="width:50%; float:left;">
                     
                        <a class="newer" href="http://www.schulichnotes.com/cardiology/2014/01/17/intro-cardiovascular-pharmacology.html"><i class="fa fa-angle-left"></i> Cardiovascular Pharmacology I</a> 
                     
                </div>
                <div style="width:50%; float:right;">
                     
                        <a class="older" href="http://www.schulichnotes.com/cardiology/2014/01/20/valvular-heart-disease-cases.html">Valvular Heart Disease Cases <i class="fa fa-angle-right"></i></a> 
                     
                </div>
            </div>
        </div>
    </div>
    <script src="http://www.schulichnotes.com/cardiology/index.js" type="text/javascript"></script>
<link rel="stylesheet" href="https://dl.dropboxusercontent.com/u/157117/notes/resources/stylesheets/search.css">	
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch_set.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/tipuesearch.js" type="text/javascript"></script>
<script src="https://dl.dropboxusercontent.com/u/157117/notes/resources/libraries/classie.js" type="text/javascript"></script>
<script>
var search = document.getElementById('header-search-icon');
var searchbar = document.getElementById('header-search-bar');
search.onclick = function(){classie.toggle(searchbar, 'search-bar-open');}
$(document).ready(function() {$('#tipue_search_input').tipuesearch();});
</script>
</body>
</html>